NO20091771L - Ny krystall av (S)-(+)-2-(2-klorfenyl)-2-hydroksyetylkarbamat - Google Patents

Ny krystall av (S)-(+)-2-(2-klorfenyl)-2-hydroksyetylkarbamat

Info

Publication number: NO20091771L
Authority: NO; Norway
Prior art keywords: hydroxyethylcarbamate; chlorophenyl; crystal; fresh crystal; fresh
Prior art date: 2006-10-06

Application number

NO20091771A

Other languages

English (en)

Norwegian (no)

Inventor

Matthew Peterson

Original Assignee

Janssen Pharmaceutica Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-10-06

Filing date

2009-05-05

Publication date

2009-05-05

2009-05-05 Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv

2009-05-05 Publication of NO20091771L publication Critical patent/NO20091771L/no

Links

239000013078 crystal Substances 0.000 title abstract 4
LBHQHDWMTSQPKV-MRVPVSSYSA-N [(2s)-2-(2-chlorophenyl)-2-hydroxyethyl]carbamic acid Chemical compound OC(=O)NC[C@@H](O)C1=CC=CC=C1Cl LBHQHDWMTSQPKV-MRVPVSSYSA-N 0.000 title abstract 2
239000008194 pharmaceutical composition Substances 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/16—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by singly-bound oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/12—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Pain & Pain Management (AREA)
Orthopedic Medicine & Surgery (AREA)
Heart & Thoracic Surgery (AREA)
Psychology (AREA)
Cardiology (AREA)
Physical Education & Sports Medicine (AREA)
Emergency Medicine (AREA)
Epidemiology (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Liquid Crystal Substances (AREA)

NO20091771A 2006-10-06 2009-05-05 Ny krystall av (S)-(+)-2-(2-klorfenyl)-2-hydroksyetylkarbamat NO20091771L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US82839206P	2006-10-06	2006-10-06
PCT/US2007/021502 WO2008045391A2 (fr)	2006-10-06	2007-10-05	Nouveau cristal de (s)-(+)-2-(2-chlorophényl)-2-hydroxy-éthyl carbamate

Publications (1)

Publication Number	Publication Date
NO20091771L true NO20091771L (no)	2009-05-05

Family

ID=39283405

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20091771A NO20091771L (no)	2006-10-06	2009-05-05	Ny krystall av (S)-(+)-2-(2-klorfenyl)-2-hydroksyetylkarbamat

Country Status (19)

Country	Link
US (1)	US7632963B2 (fr)
EP (1)	EP2076258A4 (fr)
JP (1)	JP2010505856A (fr)
KR (1)	KR20090076958A (fr)
CN (1)	CN101657195A (fr)
AU (1)	AU2007307029A1 (fr)
BR (1)	BRPI0718131A2 (fr)
CA (1)	CA2665573A1 (fr)
CO (1)	CO6180504A2 (fr)
CR (1)	CR10764A (fr)
EA (1)	EA200970355A1 (fr)
GT (1)	GT200900076A (fr)
IL (1)	IL198016A0 (fr)
MX (1)	MX2009003755A (fr)
NI (1)	NI200900050A (fr)
NO (1)	NO20091771L (fr)
SV (1)	SV2009003211A (fr)
WO (1)	WO2008045391A2 (fr)
ZA (1)	ZA200903095B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8609849B1 (en)	2010-11-30	2013-12-17	Fox Chase Chemical Diversity Center, Inc.	Hydroxylated sulfamides exhibiting neuroprotective action and their method of use
EP2797877A4 (fr) *	2011-12-27	2015-10-07	Bio Pharm Solutions Co Ltd	Composés carbamate de phényle destinés à prévenir ou à traiter la sclérose en plaques
US12054449B2 (en)	2021-08-05	2024-08-06	Bio-Pharm Solutions Co., Ltd.	Phenylcarbamate crystalline form and method for manufacturing the same
WO2023014160A1 (fr) *	2021-08-05	2023-02-09	(주)바이오팜솔루션즈	Forme cristalline de phénylcarbamate et son procédé de préparation
KR102399807B1 (ko) *	2021-08-05	2022-05-20	(주)바이오팜솔루션즈	페닐카바메이트 결정형 및 이의 제조 방법

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5698588A (en) *	1996-01-16	1997-12-16	Yukong Limited	Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol
CA2349663C (fr) *	1999-09-10	2006-10-31	Dainippon Ink And Chemicals, Inc.	Formulation de derives de quinolinone et methode de production connexe
PT1383489E (pt) *	2001-02-27	2007-06-21	Ortho Mcneil Pharm Inc	Compostos carbamato para utilização na prevenção ou tratamento de distúrbios neurodegenerativos
NZ533592A (en) *	2001-12-21	2006-05-26	Ortho Mcneil Pharm Inc	Process for preparing 2-(substituted phenyl) - 2 - hydroxy-ethyl carbamates
US7767683B2 (en) *	2003-08-18	2010-08-03	H. Lundbeck A/S	Hydrogen succinate salts of trans-4-((1R, 3S)-6-chloro-3-phenylindan-1-YL)-1,2,2-trimethylpiperazine and the use as a medicament
MX2007003278A (es) *	2004-09-16	2007-10-08	Johnson & Johnson	Uso de 2-fenil-1,2-etanodiol-(id) carbamatos para tratar epileptogenesis y epilepsia.
US20070021500A1 (en) *	2005-07-12	2007-01-25	Twyman Roy E	Methods for neuroprotection

2007
- 2007-10-05 MX MX2009003755A patent/MX2009003755A/es active IP Right Grant
- 2007-10-05 US US11/867,803 patent/US7632963B2/en not_active Expired - Fee Related
- 2007-10-05 EA EA200970355A patent/EA200970355A1/ru unknown
- 2007-10-05 AU AU2007307029A patent/AU2007307029A1/en not_active Abandoned
- 2007-10-05 CN CN200780045483A patent/CN101657195A/zh active Pending
- 2007-10-05 KR KR1020097009191A patent/KR20090076958A/ko not_active Withdrawn
- 2007-10-05 BR BRPI0718131-0A2A patent/BRPI0718131A2/pt not_active IP Right Cessation
- 2007-10-05 CA CA002665573A patent/CA2665573A1/fr not_active Abandoned
- 2007-10-05 JP JP2009531487A patent/JP2010505856A/ja not_active Withdrawn
- 2007-10-05 WO PCT/US2007/021502 patent/WO2008045391A2/fr active Application Filing
- 2007-10-05 EP EP07839353A patent/EP2076258A4/fr not_active Withdrawn
2009
- 2009-04-03 SV SV2009003211A patent/SV2009003211A/es not_active Application Discontinuation
- 2009-04-03 NI NI200900050A patent/NI200900050A/es unknown
- 2009-04-05 IL IL198016A patent/IL198016A0/en unknown
- 2009-04-06 GT GT200900076A patent/GT200900076A/es unknown
- 2009-04-07 CO CO09035814A patent/CO6180504A2/es not_active Application Discontinuation
- 2009-05-05 NO NO20091771A patent/NO20091771L/no not_active Application Discontinuation
- 2009-05-05 ZA ZA200903095A patent/ZA200903095B/xx unknown
- 2009-05-05 CR CR10764A patent/CR10764A/es not_active Application Discontinuation

Also Published As

Publication number	Publication date
WO2008045391A2 (fr)	2008-04-17
EA200970355A1 (ru)	2009-12-30
ZA200903095B (en)	2010-07-28
CR10764A (es)	2009-09-14
JP2010505856A (ja)	2010-02-25
GT200900076A (es)	2010-05-18
CN101657195A (zh)	2010-02-24
AU2007307029A1 (en)	2008-04-17
NI200900050A (es)	2010-02-01
CA2665573A1 (fr)	2008-04-17
MX2009003755A (es)	2009-07-10
IL198016A0 (en)	2009-12-24
BRPI0718131A2 (pt)	2013-11-05
CO6180504A2 (es)	2010-07-19
SV2009003211A (es)	2009-11-24
US7632963B2 (en)	2009-12-15
WO2008045391A3 (fr)	2008-06-12
EP2076258A4 (fr)	2011-09-28
KR20090076958A (ko)	2009-07-13
EP2076258A2 (fr)	2009-07-08
US20080085930A1 (en)	2008-04-10

Legal Events

Date	Code	Title	Description
2013-05-27	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
EA201000642A1 (ru)	2010-10-29	2'-фтор-2'-дезокситетрагидроуридины в качестве ингибиторов цитидиндеаминазы
EA201070786A1 (ru)	2011-02-28	Бензофуропиримидиноны
NO20084652L (no)	2008-12-03	Deazapuriner anvendelige som inhibitorer av januskinaser
EA200970581A1 (ru)	2009-12-30	Кристаллическое твёрдое основание разагилина
PH12014500053A1 (en)	2015-03-30	Proteasome inhibitors
NO20092637L (no)	2009-09-11	Fremgangsmater for behandling
NO20083002L (no)	2008-08-14	Fremgangsmate for anvendelse av CD40-bindende forbindelser
NO20092584L (no)	2009-09-14	Farmasoytiske sammensetninger og deres fremgangsmater for anvendelse
EA201200669A1 (ru)	2012-11-30	ПИРИДОПИРИМИДИНОНОВЫЕ ИНГИБИТОРЫ PI3Kα
EA201170508A1 (ru)	2011-10-31	Производные 1-амино-2-циклобутилэтилбороновой кислоты
CY1112653T1 (el)	2016-02-10	Κρυσταλλικες τροποποιησεις της πυρακλοστροβινης
EA200970156A1 (ru)	2009-08-28	Пиридизиноновые производные
EA200800760A1 (ru)	2008-08-29	ПИРИДОПИРИМИДИНОНОВЫЕ ИНГИБИТОРЫ PI3Kα
EA200870193A1 (ru)	2009-02-27	Цитотоксические агенты, включающие новые производные томаймицина, и их терапевтическое применение
EA201290183A1 (ru)	2012-12-28	Бензодиазепиновый ингибитор бромодомена
NO20090596L (no)	2009-04-01	Antivirale fosfinatforbindelser
NO20090157L (no)	2009-01-12	Tienpyrimidiner anvendelige som modulatorer av ionekanaler
NO20080141L (no)	2008-01-09	Indanderivater som modulatorer av ionekanaler
EA201170703A1 (ru)	2012-01-30	Производные адамантилбензамида
EA201070327A1 (ru)	2010-08-30	Катехоламиновые производные и их пролекарства
EA201401193A1 (ru)	2015-08-31	Триарильные соединения и композиции, их содержащие
EA201070424A1 (ru)	2011-04-29	Хиназолиндионовые производные, их получение и их применения в терапии
EA200801414A1 (ru)	2008-10-30	Кальцилитические соединения
WO2008061108A3 (fr)	2008-07-10	Dérivés de phtalazine
EA201000814A1 (ru)	2010-12-30	5-[(3,3,3-трифтор-2-гидрокси-1-арилпропил)амино]-1h-хинолин-2-оны, способ их получения и их применение в качестве противовоспалительных средств